Preterm birth and prom testing help in detecting risks of early delivery through identifying biological markers in cervical fluid or blood. This assists doctors to provide timely intervention and customized treatment plans.
Market Dynamics:
Preterm birth remains a major public health problem. Various risk factors like previous preterm birth, short interval between pregnancies, infections in uterus are leading to the growth of this market. The global preterm birth and prom testing market is driven by increasing awareness about risk factors associated with preterm birth. With growing awareness, the demand for diagnostics tests and treatments are rising. Further, implementation of various awareness and screening programs by government and non-profit organizations are also fueling the market growth. Advancements in diagnostic technology are allowing easy, quick and non-invasive detection of risks which is a key trend influencing significant market revenue gains over the forecast period.
Two Key Drivers Driving Growth In The Preterm Birth And Prom Testing Market
One of the major drivers for the growth of the preterm birth and prom testing market is the rising cases of preterm births globally. According to recent studies by WHO, preterm birth complications are the leading cause of death among children under 5 years of age, responsible for approximately 1 million deaths in 2015. Many countries are taking initiatives to increase awareness regarding the risks and issues associated with preterm births and the available diagnostic tests in the market to detect the risks. This has significantly increased the demand for various prom and fetal fibronectin tests in the market.
Another key driver has been the technological advancements in prom and fetal fibronectin testing. Various new and improved diagnostic tests have been introduced by leading players. For example, quantitative fetal fibronectin tests can more accurately determine the risk of early delivery compared to qualitative tests. Similarly, new non-invasive prom tests allow detection of prom from a simple blood draw of the mother instead of invasive procedures like cervical examinations. The availability of easy-to-use and accurate diagnostic solutions is positively impacting the growth of the overall market.
One Major Market Restrain - High Cost Of Tests
While growth drivers are positively impacting the preterm birth and prom testing market, high cost of various diagnostic tests is a major challenge being faced by industry players. Tests ranging from fetal fibronectin assays to quantitative fetal fibronectin tests require advanced equipment and trained personnel for conducting the tests and analyzing results accurately. All these factors contribute to the overall high cost of various prom and fetal fibronectin tests available in the market. This poses affordability issues especially in developing regions of the world with weak public healthcare systems. Although demand exists, many potential customers avoid opting for expensive diagnostic tests due to budget constraints. This restrain has negatively impacted sales volumes in several low and middle-income countries.
Major Market Opportunity - Emerging Markets
One of the key opportunities for players in the preterm birth and prom testing market lies in expanding to emerging market regions. While developed countries offer a largely saturated customer base, high growth opportunities exist in developing Asian, African, Middle Eastern and Latin American markets. Factors such as rising healthcare investments, growing medical tourism, increasing per capita incomes and escalating cases of preterm deliveries in these regions are turning them into lucrative markets. Players need to introduce low-cost product offerings, establish local manufacturing and distribution networks and raise awareness through promotional campaigns to successfully tap opportunities in emerging markets. Entering high growth territories at an early stage will help establishments gain a strong foothold and reap long term rewards.
Trend Towards Non-Invasive Diagnostic Methods
A major trend being witnessed in the preterm birth and prom testing market is the increasing shift and focus towards non-invasive diagnostic methods. Compared to traditional invasive techniques, non-invasive variants provide significant advantages to both patients and healthcare providers. Benefits like elimination of risks related to needle sticks, reduced pain and discomfort, ability to detect prom early at point-of-care locations and automated platforms for high-throughput processing are fueling their popularity. Most leading brands are aggressively investing in R&D to come up with novel non-invasive prom detection applications based on techniques like analysis of circulatory RNA, exosomes and cell-free DNA levels. This ongoing shift towards easy-to-use, pain-free and highly accurate non-invasive prom testing solutions is expected to define future growth trajectories in the market.
The Preterm Birth And PROM Testing Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countriesThe research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the preterm birth and PROM testing market include Abbott Laboratories, Biosynex, Clinical Innovations, LLC, Cooper Companies, Inc., Hologic, Inc., IQ Products, Medix Biochemica, NX Prenatal, Inc., QIAGEN, and Sera Prognostics, Inc.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Preterm Birth And PROM Testing Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/preterm-birth-and-prom-testing-market/download-sampleMarket DynamicsThe increasing number of preterm births due to the rising average number of women being pregnant is primarily driving the market growth.
The rising various health issues such as diabetes and high blood pressure among women is also fuelling the demand for preterm birth and PROM testing.
However, the availability of alternative diagnostic options such as ultrasound, transvaginal scan, uterine monitoring, and lab tests are likely to hamper the market growth.
Transparency Market Research (TMR) has published a new report titled, “Preterm Birth and PROM Testing - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.
Increase in number of preterm births, growth of the medical diagnostics industry in emerging economies in regions such as Asia Pacific, and adoption of latest technologies and techniques to access or diagnose preterm births are projected to augment the global market between 2018 and 2026.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=55416Increase in Preterm Births to Propel MarketSedentary lifestyle along with several other factors has led to increase in preterm births, which has become a major concern in the past few years.
Point-of-care testing devices have also assisted in reducing the chances of complications due to preterm births by enabling diagnosis at early stages and allowing health care providers to offer immediate care to mother and fetus at early stages of pregnancy.Request COVID Analysis on Preterm Birth and PROM Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=55416Lack of Awareness about Preterm Births to Restrain MarketLack of awareness about preterm births and PROM could lead to longer hospital stays and preventable expenditure from the perspective of patients.
Additionally, lack of awareness about availability of latest technologies available for diagnosis of premature births, resulting in delayed diagnosis and treatment is one of the major factors hampering the growth of the market.Request Customization on Preterm Birth and PROM Testing Market Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=55416Asia Pacific Market to Grow at a Rapid PaceIn terms of revenue, the preterm birth and PROM testing market in Asia Pacific is projected to expand at a high CAGR during the forecast period.
Furthermore, surge in awareness about women’s health and increase in expenditure on health care in the region are anticipated to present lucrative opportunities in the market in the next few years.Buy Preterm Birth and PROM Testing Market Report –https://www.transparencymarketresearch.com/checkout.php?rep_id=55416=SCollaborative Efforts by Key Players to Boost MarketThe report also provides profiles of leading players operating in the global preterm and PROM testing market.
These include NX Prenatal, Inc., IQ Products, QIAGEN, Hologic, Inc., The Cooper Companies, Inc., Medix Biochemica, Abbott Laboratories, Clinical Innovations, LLC, Sera Prognostics, Inc., and Biosynex.
